| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 39.63▼ | 39.59▲ | 39.60▼ | 39.43▲ | 39.28▲ |
| MA10 | 39.63▼ | 39.59▲ | 39.60▼ | 39.03▲ | 38.96▲ |
| MA20 | 39.60▲ | 39.59▲ | 39.54▲ | 39.36▲ | 38.33▲ |
| MA50 | 39.60▼ | 39.50▲ | 39.21▲ | 38.87▲ | 36.27▲ |
| MA100 | 39.61▼ | 39.13▲ | 39.17▲ | 38.18▲ | 32.59▲ |
| MA200 | 39.56▲ | 39.22▲ | 39.39▲ | 37.00▲ | 31.00▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.009▼ | -0.015▼ | 0.023▲ | -0.039▼ |
| RSI | 47.991▼ | 53.664▲ | 57.482▲ | 56.556▲ | 63.048▲ |
| STOCH | 78.235 | 35.331 | 47.127 | 76.239 | 66.570 |
| WILL %R | -42.857 | -73.333 | -32.836 | -14.354▲ | -23.107▲ |
| CCI | -42.217 | -33.983 | 42.754 | 87.541 | 93.067 |
|
Wednesday, November 12, 2025 02:21 PM
Ascendis Pharma Reports Third Quarter 2025 Financial Results. – Q3 2025 revenue of €143.1 million for YORVIPATH®and €50.7 million for SKYTROFA® – Q3 2025 operating profit of €11.0 million – TransCon® ...
|
|
Wednesday, November 12, 2025 01:21 PM
Despite the revenue growth, operating expenses increased to €180.3 million from €143.4 million in the same period last year, primarily due to global commercial expansion and YORVIPATH launch ...
|
|
Wednesday, November 12, 2025 03:14 AM
Analysts expect the Hellerup, Denmark-based company to report a quarterly loss at 16 cents per share, versus a year-ago loss of $1.72 per share. The consensus estimate for Ascendis Pharma's quarterly ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 39.73 | 39.82 | 39.52 | 39.60 | 2,230,805 |
| 11/11/25 | 39.55 | 39.73 | 39.145 | 39.69 | 3,031,356 |
| 10/11/25 | 39.18 | 39.725 | 39.16 | 39.48 | 3,565,976 |
| 07/11/25 | 39.07 | 39.46 | 39.03 | 39.41 | 4,178,409 |
| 06/11/25 | 38.83 | 39.41 | 38.80 | 38.99 | 4,215,011 |
| 05/11/25 | 38.74 | 39.02 | 38.475 | 38.86 | 6,229,328 |
| 04/11/25 | 38.61 | 38.83 | 38.27 | 38.74 | 4,933,920 |
| 03/11/25 | 38.12 | 38.485 | 37.81 | 38.42 | 6,962,847 |
| 31/10/25 | 38.68 | 38.7673 | 38.24 | 38.24 | 5,805,859 |
| 30/10/25 | 39.04 | 39.39 | 38.875 | 38.91 | 3,346,261 |
|
|
||||
|
|
||||
|
|